With so many patients choosing BTK inhibitors for their Waldenstrom Macroglobulinemia treatment, and new WM treatments in development, it is difficult to keep up with so much new information. This is your chance to get Dr. Jorge Castillo's expert info about BTK inhibitors, long term goals and monitoring; what to do, what not to do; complications; and even some success stories.

IWMF grant funding for research projects has helped to provide an understanding of the basic biology and genetics of WM. This research in turn has played a significant role in the development of treatments and treatment guidelines in current use, as well as potential new drugs still in the pipeline. The goal of our research program is to improve quality of life for WM patients and, ultimately, discover a cure.

Waldenstrom’s macroglobulinemia (WM) is a rare type of cancer that begins in the white blood cells.The abnormal white blood cells produce a protein that accumulates in the blood, impairs circulation and causes complications. It continues to be a clinical challenge for treating physicians as complete remissions and prevention of relapse are few in spite of all the therapeutic tools that are currently available.  Besides treatment aspects, correct diagnosis of WM often poses a challenge.

For the 22nd consecutive year, Dana-Farber Brigham Cancer Center has been recognized as a Best Hospital for cancer care by U.S. News & World Report. This year, Dana-Farber Brigham Cancer Center is ranked as the best hospital for cancer care in New England and #4 in the nation.

Join us for the Walk for Waldenstrom’s 2022, Sunday, September 18th at 10:00am (ET). This is YOUR opportunity to raise awareness and support for the International Waldenstrom’s Macroglobulinemia Foundation (IWMF). Walk for Waldenstrom’s is a 1-mile walk/run fundraising and awareness event for the IWMF and global WM community of care partners, friends, and family. There’s no registration fee or charge!

The International Waldenstrom’s Macroglobulinemia Foundation (IWMF) is a patient-founded, patient-led, international non-profit that is dedicated to a simple but compelling vision: Support everyone affected by Waldenstrom’s macroglobulinemia (WM) while advancing the search for a cure.

The 27th Annual IWMF Educational Forum provides a unique opportunity to learn and connect with and from one another. The 2022 Virtual Ed Forum brings WM specialists, clinicians, researchers, patients, and caregivers together. A two-day program features pertinent and timely information related to symptoms and complications of WM, current treatment options, new therapies, and life topics that align with this year’s Ed Forum theme:  Living, Learning, and Thriving with WM. This year’s Educational Forum will conclude with our popular “Ask the Doctors” question-and-answer session.

A project that has been a long time in the making came to fruition earlier this year.  The goal of the WMFC was to have a series of video conferences led by key WM researchers, and to specifically invite Canadian Medical Professionals to learn more about our disease from those who know it best.

Rare Cancers Updates offers a dynamic half-day online learning experience aimed at helping clinicians efficiently gain valuable education on a rare topic. You'll have the opportunity to earn CME credits and compete for amazing prizes during our 2022 Contest! Join us during the June 17th meeting, where you'll gain insights and practical guidance on Waldenström Macroglobulinemia. Registration is free!

WM patients and caregivers under the age of 50:Join the Young WM International Support Group on May 16th with special guest, Dr. Shayna Sarosiek!